Law-Now
19 Feb 2026 ·
International
Can Switzerland protect patient access to innovative medicines in era of most-favoured-nation pricing?
1 min read
Authors
The US is reshaping global pharmaceutical pricing. With the introduction of a most-favoured-nation pricing model for new and innovative medicines, the US is seeking to align domestic prices with those paid in other countries. The effects of this change will be...
Read more